The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 6, 2025 | Russell Angus C. | Director | Disposed to issuer(D) | 15K | — | — |
| Feb 6, 2025 | Nolet Chris | Director | Disposed to issuer(D) | 15K | — | — |
| Feb 6, 2025 | Beraud Jill | Director | Disposed to issuer(D) | 15K | — | — |
| Feb 6, 2025 | Coric Vlad | Director | Disposed to issuer(D) | 15K | — | — |
| Feb 6, 2025 | Kolaja Carey OConnor | Director | Disposed to issuer(D) | 15K | — | — |
| Feb 6, 2025 | Ware Olivia C | Director | Disposed to issuer(D) | 15K | — | — |
| Feb 6, 2025 | Jordan Erica | Chief Commercial Officer | Disposed to issuer(D) | 108K | — | — |
| Feb 6, 2025 | Hollander David | CMO & Global Therapeutics Lead | Disposed to issuer(D) | 95K | — | — |
| Feb 6, 2025 | Moxie Dwight | CLO & GC | Disposed to issuer(D) | 18K | — | — |
| Feb 6, 2025 | Moxie Dwight | CLO & GC | Grant(A) | 18K | — | $0 |
| Feb 6, 2025 | Moxie Dwight | CLO & GC | Disposed to issuer(D) | 96K | — | — |
| Feb 6, 2025 | Schilke Tobin | CFO | Disposed to issuer(D) | 21K | — | — |
| Feb 6, 2025 | Schilke Tobin | CFO | Disposed to issuer(D) | 104K | — | — |
| Feb 6, 2025 | Schilke Tobin | CFO | Grant(A) | 21K | — | $0 |
| Feb 6, 2025 | Foley Mark J | President & CEO, Director | Grant(A) | 85K | — | $0 |
| Feb 6, 2025 | Foley Mark J | President & CEO, Director | Disposed to issuer(D) | 28K | — | — |
| Feb 6, 2025 | Foley Mark J | President & CEO, Director | Disposed to issuer(D) | 85K | — | — |
| Feb 6, 2025 | Gangolli Julian S | Director | Disposed to issuer(D) | 15K | — | — |
| Feb 4, 2025 | Russell Angus C. | Director | Tender(U) | 37K | $3.65 | $133K |
| Feb 4, 2025 | Nolet Chris | Director | Tender(U) | 29K | $3.65 | $104K |
| Feb 4, 2025 | Beraud Jill | Director | Tender(U) | 29K | $3.65 | $104K |
| Feb 4, 2025 | Coric Vlad | Director | Tender(U) | 6K | $3.65 | $21K |
| Feb 4, 2025 | Kolaja Carey OConnor | Director | Tender(U) | 17K | $3.65 | $60K |
| Feb 4, 2025 | Ware Olivia C | Director | Tender(U) | 17K | $3.65 | $61K |
| Feb 4, 2025 | Jordan Erica | Chief Commercial Officer | Tender(U) | 7K | $3.65 | $25K |
| Feb 4, 2025 | Hollander David | CMO & Global Therapeutics Lead | Tender(U) | 10K | $3.65 | $36K |
| Feb 4, 2025 | Moxie Dwight | CLO & GC | Tender(U) | 48K | $3.65 | $175K |
| Feb 4, 2025 | Schilke Tobin | CFO | Tender(U) | 98K | $3.65 | $358K |
| Feb 4, 2025 | Foley Mark J | President & CEO, Director | Tender(U) | 997K | $3.65 | $3.6M |
| Feb 4, 2025 | Foley Mark J | President & CEO, Director | Tender(U) | 111K | $3.65 | $405K |
| Feb 4, 2025 | Gangolli Julian S | Director | Tender(U) | 30K | $3.65 | $110K |
| Feb 3, 2025 | Moxie Dwight | CLO & GC | Grant(A) | 6K | — | $0 |
| Feb 3, 2025 | Schilke Tobin | CFO | Grant(A) | 7K | — | $0 |
| Feb 3, 2025 | Foley Mark J | CEO, Director | Grant(A) | 28K | — | $0 |
| Dec 31, 2024 | Foley Mark J | CEO, Director | Grant(A) | 1K | $2.18 | $2K |
| Dec 31, 2024 | Schilke Tobin | CFO | Grant(A) | 1K | $2.18 | $2K |
| Nov 18, 2024 | Hollander David | CMO & Global Therapeutics Lead | Sell(S) | 4K | $4.17 | $16K |
| Jun 30, 2024 | Schilke Tobin | CFO | Grant(A) | 1K | $2.18 | $2K |
| Jun 30, 2024 | Foley Mark J | CEO, Director | Grant(A) | 1K | $2.18 | $2K |
| May 1, 2024 | Beraud Jill | Director | Grant(A) | 15K | — | $0 |
| May 1, 2024 | Beraud Jill | Director | Grant(A) | 23K | — | $0 |
| May 1, 2024 | Coric Vlad | Director | Grant(A) | 15K | — | $0 |
| May 1, 2024 | Coric Vlad | Director | Grant(A) | 23K | — | $0 |
| May 1, 2024 | Gangolli Julian S | Director | Grant(A) | 15K | — | $0 |
| May 1, 2024 | Gangolli Julian S | Director | Grant(A) | 23K | — | $0 |
| May 1, 2024 | Kolaja Carey OConnor | Director | Grant(A) | 15K | — | $0 |
| May 1, 2024 | Kolaja Carey OConnor | Director | Grant(A) | 23K | — | $0 |
| May 1, 2024 | Nolet Chris | Director | Grant(A) | 15K | — | $0 |
| May 1, 2024 | Nolet Chris | Director | Grant(A) | 23K | — | $0 |
| May 1, 2024 | Russell Angus C. | Director | Grant(A) | 15K | — | $0 |
| May 1, 2024 | Russell Angus C. | Director | Grant(A) | 23K | — | $0 |
| May 1, 2024 | Ware Olivia C | Director | Grant(A) | 15K | — | $0 |
| May 1, 2024 | Ware Olivia C | Director | Grant(A) | 23K | — | $0 |
| Apr 16, 2024 | Jordan Erica | Chief Commercial Officer | Sell(S) | 2K | $3.80 | $9K |
| Mar 18, 2024 | Schilke Tobin | CFO | Sell(S) | 9K | $5.04 | $47K |
| Mar 18, 2024 | Moxie Dwight | CLO & GC | Sell(S) | 8K | $5.04 | $41K |
| Mar 18, 2024 | Sjuts Dustin S | President | Sell(S) | 9K | $5.04 | $46K |
| Mar 15, 2024 | Foley Mark J | CEO, Director | Tax withholding(F) | 3K | $5.31 | $18K |
| Mar 15, 2024 | Foley Mark J | CEO, Director | Tax withholding(F) | 17K | $5.31 | $91K |
| Mar 15, 2024 | Schilke Tobin | CFO | Tax withholding(F) | 4K | $5.31 | $20K |
| Mar 15, 2024 | Moxie Dwight | CLO & GC | Tax withholding(F) | 3K | $5.31 | $17K |
| Mar 15, 2024 | Sjuts Dustin S | President | Tax withholding(F) | 3K | $5.31 | $16K |
| Mar 6, 2024 | Foley Mark J | CEO, Director | Buy(P) | 30K | $6.98 | $209K |
| Feb 29, 2024 | Foley Mark J | CEO, Director | Grant(A) | 71K | — | $0 |
| Feb 29, 2024 | Schilke Tobin | CFO | Grant(A) | 17K | — | $0 |
| Feb 29, 2024 | Moxie Dwight | CLO & GC | Grant(A) | 15K | — | $0 |
| Feb 29, 2024 | Sjuts Dustin S | President | Grant(A) | 22K | — | $0 |
| Jan 31, 2024 | Foley Mark J | CEO, Director | Grant(A) | 1.1M | — | $0 |
| Jan 31, 2024 | Schilke Tobin | CFO | Grant(A) | 97K | — | $0 |
| Jan 31, 2024 | Schilke Tobin | CFO | Grant(A) | 145K | — | $0 |
| Jan 31, 2024 | Moxie Dwight | SVP, GC & Secretary | Grant(A) | 90K | — | $0 |
| Jan 31, 2024 | Moxie Dwight | SVP, GC & Secretary | Grant(A) | 135K | — | $0 |
| Dec 31, 2023 | Foley Mark J | CEO, Director | Grant(A) | 264 | $7.47 | $2K |
| Dec 31, 2023 | Schilke Tobin | CFO | Grant(A) | 434 | $7.47 | $3K |
| Dec 31, 2023 | Sjuts Dustin S | President | Grant(A) | 264 | $7.47 | $2K |
| Dec 15, 2023 | Sjuts Dustin S | President | Tax withholding(F) | 5K | $8.08 | $38K |
| Sep 6, 2023 | Moxie Dwight | SVP, GC & Secretary | Sell(S) | 11K | $17.06 | $188K |
| Sep 5, 2023 | Moxie Dwight | SVP, GC & Secretary | Sell(S) | 24K | $17.81 | $425K |
| Aug 11, 2023 | Foley Mark J | CEO, Director | Tax withholding(F) | 48K | $18.91 | $909K |
| Aug 11, 2023 | Foley Mark J | CEO, Director | Grant(A) | 122K | — | $0 |
| Aug 11, 2023 | Sjuts Dustin S | President | Tax withholding(F) | 9K | $18.91 | $168K |
| Aug 11, 2023 | Sjuts Dustin S | President | Grant(A) | 23K | — | $0 |
| Aug 11, 2023 | Moxie Dwight | SVP, GC & Secretary | Tax withholding(F) | 10K | $18.91 | $181K |
| Aug 11, 2023 | Moxie Dwight | SVP, GC & Secretary | Grant(A) | 19K | — | $0 |
| Aug 11, 2023 | Schilke Tobin | CFO | Tax withholding(F) | 11K | $18.91 | $212K |
| Aug 11, 2023 | Schilke Tobin | CFO | Grant(A) | 23K | — | $0 |
| Aug 3, 2023 | Foley Mark J | CEO, Director | Sell(S) | 26K | $22.57 | $593K |
| Jul 3, 2023 | Foley Mark J | CEO, Director | Sell(S) | 26K | $24.94 | $655K |
| Jul 3, 2023 | Schilke Tobin | CFO | Sell(S) | 2K | $25.04 | $43K |
| Jun 30, 2023 | Foley Mark J | CEO, Director | Grant(A) | 1K | $15.61 | $16K |
| Jun 30, 2023 | Sjuts Dustin S | President | Grant(A) | 1K | $15.61 | $16K |
| Jun 30, 2023 | Schilke Tobin | CFO | Grant(A) | 769 | $15.61 | $12K |
| Jun 15, 2023 | Kolaja Carey OConnor | Director | Sell(S) | 3K | $28.24 | $71K |
| Jun 15, 2023 | Kolaja Carey OConnor | Director | Option exercise(M) | 3K | $18.12 | $45K |
| Jun 15, 2023 | Kolaja Carey OConnor | Director | Option exercise(M) | 3K | — | $0 |
| Jun 9, 2023 | Foley Mark J | CEO, Director | Sell(S) | 31K | $30.72 | $961K |
| Jun 9, 2023 | Sjuts Dustin S | President | Sell(S) | 5K | $30.82 | $154K |
| Jun 2, 2023 | Schilke Tobin | CFO | Sell(S) | 500 | $31.00 | $16K |
| Jun 1, 2023 | Schilke Tobin | CFO | Sell(S) | 3K | $30.57 | $83K |
| May 15, 2023 | Sjuts Dustin S | President | Sell(S) | 21K | $34.55 | $726K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).